GBE Stock Overview Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Genus Historical stock prices Current Share Price UK£18.30 52 Week High UK£27.02 52 Week Low UK£18.30 Beta 0.35 1 Month Change -11.17% 3 Month Change -18.30% 1 Year Change -24.00% 3 Year Change -67.89% 5 Year Change -50.57% Change since IPO 44.69%
Recent News & Updates
Genus plc to Report Fiscal Year 2025 Results on Sep 04, 2025 Nov 30
Genus plc Declares A Final Dividend Nov 21
Genus plc to Report First Half, 2025 Results on Feb 27, 2025 Nov 20
Now 22% undervalued Nov 06
Upcoming dividend of UK£0.22 per share Nov 01 Genus plc Announces Retirement of Alison Henriksen as Chief Financial Officer, Until 31 July 2025 Oct 22
See more updates
Genus plc to Report Fiscal Year 2025 Results on Sep 04, 2025 Nov 30
Genus plc Declares A Final Dividend Nov 21
Genus plc to Report First Half, 2025 Results on Feb 27, 2025 Nov 20
Now 22% undervalued Nov 06
Upcoming dividend of UK£0.22 per share Nov 01 Genus plc Announces Retirement of Alison Henriksen as Chief Financial Officer, Until 31 July 2025 Oct 22
Full year 2024 earnings released: EPS: UK£0.12 (vs UK£0.51 in FY 2023) Oct 15
Final dividend of UK£0.22 announced Sep 08
Full year 2024 earnings released: EPS: UK£0.12 (vs UK£0.51 in FY 2023) Sep 06
Genus plc Proposes Final Dividend for the Year Ended June 30, 2024, Payable on 6 December 2024 Sep 05
Now 24% undervalued after recent price drop Aug 06
New minor risk - Share price stability Jul 29
Investor sentiment deteriorates as stock falls 16% Mar 06
First half dividend of UK£0.10 announced Feb 25
First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023) Feb 23
Investor sentiment deteriorates as stock falls 19% Feb 17
Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024 Feb 16
Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024 Feb 15
Genus Appoints Ralph Heuser as Non-Executive Director, with effect from 1 January 2024 Dec 12 Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024
New minor risk - Share price stability Nov 24
Genus plc Approves to Declare Final Dividend Nov 23
Upcoming dividend of UK£0.22 per share at 1.5% yield Nov 02
Full year 2023 earnings released: EPS: UK£0.51 (vs UK£0.63 in FY 2022) Oct 15
Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs Oct 08
Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs Oct 07
New minor risk - Earnings quality Sep 11
Full year 2023 earnings released: EPS: UK£0.51 (vs UK£0.63 in FY 2022) Sep 08
Genus plc Announces Lykele Van Der Broek to Step Down from the Genus Board Aug 24
AB Agri Ltd. completed the acquisition of National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd. Aug 11
New minor risk - Dividend sustainability Jun 27
AB Agri Ltd. made an offer to acquire National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd £45.7 million. Jun 07
First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022) Feb 24 Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023
Investor sentiment improved over the past week Nov 12
Upcoming dividend of UK£0.22 per share Nov 10
Investor sentiment improved over the past week Oct 20
Investor sentiment improved over the past week Sep 15
Full year 2022 earnings released: EPS: UK£0.63 (vs UK£0.73 in FY 2021) Sep 09
Genus plc Proposes Final Dividend, Payable on 9 December 2022 Sep 08
Investor sentiment improved over the past week Jul 26
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat Feb 27
Genus plc Proposes Interim Dividend, Payable on March 31, 2022 Feb 24
Genus plc to Report First Half, 2022 Results on Feb 24, 2022 Feb 17
Independent Non-Executive Chairman recently bought €267k worth of stock Nov 25
Upcoming dividend of UK£0.22 per share Nov 11
Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.54 in FY 2020) Oct 17
Chief Operating Officer recently sold €396k worth of stock Oct 15
Insider recently sold €1.6m worth of stock Sep 15
Genus plc (LSE:GNS) acquired Trade and assets of Sergal Gestio Ramadera, S.L. from Sergal Gestio Ramadera Sl for £7.7 million. Sep 10
Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.62 in FY 2020) Sep 10
Independent Non-Executive Director Ian Charles has left the company Jun 09
Independent Non-Executive Chairman recently bought €84k worth of stock Apr 02
Independent Non-Executive Chairman recently bought €84k worth of stock Feb 28
First half 2021 earnings released: EPS UK£0.48 (vs UK£0.36 in 1H 2020) Feb 28 Genus plc to Report Fiscal Year 2021 Results on Sep 09, 2021
New 90-day high: €62.50 Feb 10
New 90-day high: €50.00 Jan 19
Genus plc to Report Q2, 2021 Results on Feb 25, 2021 Jan 19
CEO & Executive Director recently sold €989k worth of stock Dec 04
Genus plc Announces Executive Changes Nov 26
Upcoming Dividend of UK£0.20 Per Share Nov 12
New 90-day high: €46.18 Nov 05
Full year earnings released - EPS €0.62 Oct 19
Annual earnings released: Revenue beats expectations Oct 19
New 90-day high: €44.12 Oct 12
New 90-day high - €43.12 Sep 10 Shareholder Returns GBE DE Biotechs DE Market 7D -6.6% -1.2% -1.4% 1Y -24.0% -13.2% 8.0%
See full shareholder returns
Return vs Market: GBE underperformed the German Market which returned 8.1% over the past year.
Price Volatility Is GBE's price volatile compared to industry and market? GBE volatility GBE Average Weekly Movement 4.5% Biotechs Industry Average Movement 6.7% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.9% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: GBE has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GBE's weekly volatility (4%) has been stable over the past year.
About the Company Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Show more Genus plc Fundamentals Summary How do Genus's earnings and revenue compare to its market cap? GBE fundamental statistics Market cap €1.24b Earnings (TTM ) €9.59m Revenue (TTM ) €811.59m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) GBE income statement (TTM ) Revenue UK£668.80m Cost of Revenue UK£413.50m Gross Profit UK£255.30m Other Expenses UK£247.40m Earnings UK£7.90m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
Earnings per share (EPS) 0.12 Gross Margin 38.17% Net Profit Margin 1.18% Debt/Equity Ratio 42.9%
How did GBE perform over the long term?
See historical performance and comparison Dividends
2.1% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/18 16:38 End of Day Share Price 2024/12/18 00:00 Earnings 2024/06/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Genus plc is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Robert Chantry Berenberg Francesco Gregori Charles Stanley Securities Benjamin Moore Goldman Sachs
Show 15 more analysts 
